Drawing for CONSILIENT

USPTO serial 76376927

CONSILIENT

Reviewed by CopyMark Law Group

Reg. 2793783Status 710
Filing date
Status date
Registration date
Dec 16, 2003
Examiner
POWERS, ALEXANDER L
Law office
SCANNING ON DEMAND

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with CONSILIENT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Raymond C. Stewart

RAYMOND C STEWART BIRCH, STEWART, KOLASCH & BIRCH, LLPP O BOX 747FALLS CHURCH, VA 22040-0747UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for use in the treatment of diseases or conditions of the alimentary system, the circulatory system, the central nervous system, the endocrine system, the musculo-skeletal system and the respiratory system; anti-infectives; immunological pharmaceutical preparations; dietary supplements; analgesics; otolaryngological pharmaceutical preparations; ophthalmological pharmaceutical preparations; anti-allergic pharmaceutical preparations; dermatological pharmaceutical preparations; oral contraceptives; obstetric and gynecological pharmaceutical preparations; antidotes; medical diagnostic reagents and pharmaceutical preparations for the treatment of neoplastic disorders; sanitary napkins and pads, tampons; food for medically restricted diets; medical plasters; dressings for the treatment of wounds, burns and surgical dressings; all purpose disinfectantsSECTION 8 - CANCELLED—
010Dental devices, namely dental implants and orthodontic appliances; medical devices, namely, transdermal drug delivery patches sold without medication; drug delivery devices sold without medication for the administration of pharmaceutical preparations and substances, said devices having one or more hollow needles for penetrating the skin of a patiend and for delivering medication from a reservoir in the device when filled with medication; aerosol dispensers for medical use; anesthetic delivery apparatus, namely, intubation devices including endotracheal, nasal, nasotracheal and orotracheal tubes; anesthetic masks; inhalers; medical infusion and perfusion apparatus; intravenous drips; medical apparatus for diagnosing diseases or conditions of the alimentary system, the circulatory system, the central nervous system, the endocrine system, the musculo skeletal system and the respiratory system; diaphragms and intrauterine devices for contraceptive use; drainage tubes for medical purposes; prosthetic devices for use in the correction of deformities of bones and muscles, namely orthopedic prostheses; artificial body parts, namely breast prostheses and artificial breasts, artificial bones, artificial eyes, artificial jaws, artificial limbs; orthopedic devices, namely fixators for leg straightening and lengthening, pins and plates for use in the treatment of fractures and breakages of bones; cannulae; catheters; drug delivery pens for the administration of adrenaline for use in the treatment of anaphylactic shock; surgical clips; surgical stapeles; elastic, supportive and suspensory bandagesSECTION 8 - CANCELLED—
035Association services, namely, promoting the interests of the pharmaceutical industry by interaction with regulatory authoritiesSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 24, 2010C8..CANCELLED SEC. 8 (6-YR)—
Jun 7, 2007CFITCASE FILE IN TICRS—
Dec 16, 2003R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 23, 2003PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 3, 2003NPUBNOTICE OF PUBLICATION—
Jul 17, 2003CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 17, 2003CNEAEXAMINERS AMENDMENT MAILED—
Jun 13, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 13, 2003MAILPAPER RECEIVED—
Mar 7, 2003CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 13, 200244DDSEC. 44(D) CLAIM DELETED—
Dec 13, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 13, 2002MAILPAPER RECEIVED—
Jun 18, 2002CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 7, 2002DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance